Jesus Fabregas Mercado practices Oncology. He received awards:"American College of Physicians Outstanding Resident". Dr. Jesus C. Fabregas Mercado is also a published MD. He has 5 publication published. The most recent publication is: Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma.
![]() |
Dr. Mark T. O'Connell, MD
![]() |
![]() |
Dr. Alejandro Vilasuso, MD
![]() |
![]() |
Dr. Abdulla Al-Damluji, MD |
![]() |
Dr. Melissa R. Tseng, MD
![]() |
![]() |
Dr. Catherine W. Froelich, MD |
![]() |
Dr. Andres Reyes Corcho, MD
![]() |
![]() |
Dr. Pasquale W. Benedetto, MD
![]() |
![]() |
Dr. Michael B. Troner, MD
![]() ![]() |
![]() |
Dr. Breelyn A. Wilky, MD
![]() ![]() |
![]() |
Dr. Barry M. Kinzbrunner, MD
![]() ![]() |
![]() |
Dr. Donald S. Ernst, MD
![]() |